Application 062832
- Type
- ANDA
- Sponsor
- SOCORRO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NYSTATIN | NYSTATIN | SUSPENSION;ORAL | 100,000 UNITS/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A062832-001 | NYSTATIN | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 1991-12-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A062832-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A062832-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 1991-12-27 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A062832-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NYSTATIN | NYSTATIN | Kesin Pharma Corporation | 50737729-a4a4-e747-e063-6394a90adcc5 | 2026-06-30 | Adverse reactions | 062832 ANDA062832 |
| NYSTATIN | NYSTATIN | Bryant Ranch Prepack | 4f6f59fb-ae7d-48e5-b23e-a1d92160974f | 2026-05-11 | Adverse reactions | 062832 ANDA062832 |
| NYSTATIN | NYSTATIN | Kesin Pharma Corporation | 43817169-bbe8-58ee-e063-6294a90a1250 | 2025-12-11 | Adverse reactions | 062832 ANDA062832 |
| NYSTATIN | NYSTATIN | Kanchan Healthcare Inc | 90a52c3f-3ef7-4f3b-9fe5-40af408e9f2a | 2025-09-12 | Adverse reactions | 062832 ANDA062832 |
| NYSTATIN | NYSTATIN | Bryant Ranch Prepack | b06c65cd-5b65-4bc6-aae9-b9381c6f1948 | 2023-01-26 | Adverse reactions | 062832 ANDA062832 63629-8520 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 63629-2492 | NYSTATIN | NYSTATIN | Bryant Ranch Prepack | ANDA | Current |
| 63629-2492 | NYSTATIN | NYSTATIN | Bryant Ranch Prepack | ANDA | Current |
| 63629-2492 | NYSTATIN | NYSTATIN | Bryant Ranch Prepack | ANDA | Current |
| 63629-2492 | NYSTATIN | NYSTATIN | Bryant Ranch Prepack | ANDA | Current |
| 63629-2493 | NYSTATIN | NYSTATIN | Bryant Ranch Prepack | ANDA | Current |
| 63629-2493 | NYSTATIN | NYSTATIN | Bryant Ranch Prepack | ANDA | Current |
| 63629-2493 | NYSTATIN | NYSTATIN | Bryant Ranch Prepack | ANDA | Current |
| 63629-2493 | NYSTATIN | NYSTATIN | Bryant Ranch Prepack | ANDA | Current |
| 63629-8520 | NYSTATIN | NYSTATIN | Bryant Ranch Prepack | ANDA | Current |
| 63629-8520 | NYSTATIN | NYSTATIN | Bryant Ranch Prepack | ANDA | Current |
| 75834-235 | NYSTATIN | NYSTATIN | Nivagen Pharmaceuticals, Inc. | ANDA | Current |
| 75834-235 | NYSTATIN | NYSTATIN | Nivagen Pharmaceuticals, Inc. | ANDA | Current |